This is the Best-Selling Covid Vaccine in the World

According to data from the University of Oxford's Our World In Data until February 22, 2021, there are 208.2 million more Covid-19 vaccines that have been injected into humans. That is the equivalent of 2.7 doses per 200 people.

Based on these data, Israel is the country that is the fastest to administer vaccines to its citizens. As many as 49.2% of its citizens have been injected with the Covid-19 vaccine. Then there is the Seychelles country which has vaccinated 44.9% of its citizens.

Now, there are currently 9 Covid-19 vaccines in the world that have received an emergency use (UEA) permit. The most widely used vaccine is the Pfizer-BioNTech vaccine. There are 65 countries that have used this vaccine.

against Covid-19 virus infection in the body and 100% effective in preventing severe disease due to Covid-19.

 

The second place is AstraZeneca, which has been used by 46 countries. The vaccine is 75% effective on average against Covid-19 virus infection in the body.

The following is a list of the most widely used Covid-19 vaccines in the world, as quoted from the New York Times, Tuesday (23/2/2021):

https://www.geogebra.org/m/cgurmr79

https://www.geogebra.org/m/hm3ydc9k

https://www.geogebra.org/m/rfmc5eqa

https://www.stockportgolf.co.uk/forums/topic/putlockers-hd-watch-chaos-walking-2021-online-full/

https://www.stockportgolf.co.uk/forums/topic/free-watch-judas-and-the-black-messiah-2021-full-hd/

Pfizer-BioNTech: 65 countries

Oxford-AstraZeneca: 46 countries

Moderna: 27 countries

Sinopharm-Beijing: 11 countries

Sputnik V (Russia): 10 countries

Sinovac: 6 countries

Sinopharm-Wuhan: 2 countries

Bharat Biotech: 1 country

Johnson & Johnson: 1 state.

The world faces "catastrophic moral failure" due to the unequal Covid-19 vaccine policy , said the Director General of the World Health Organization ( WHO ). Tedros Adhanom Ghebreyesus said it was unfair for young and healthy people in rich countries to get the injection before vulnerable people got it in poorer countries. He said more than 39 million doses of the vaccine had been given in 49 rich countries - but one poor country had only 25 doses.

 

Meanwhile, WHO and China have been criticized for their response to Covid-19. An independent panel commissioned by the WHO said the UN's public health agency should have declared an international emergency earlier, and also criticized China for not taking health action earlier. So far, China, India, Russia, UK and the US have all developed a Covid-19 vaccine, while other vaccines are made by multinational teams - such as the American-German Pfizer vaccine. Almost all of these countries prioritize distribution to their own citizens.

What does the WHO head say? In a WHO executive board session on Monday, Dr Tedros said , "I have to be honest: the world is on the verge of a catastrophic failure - and the price of this failure will be paid for with life and life in the poorest countries in the world." Dr Tedros said the "me first" approach would be self-defeating because it would drive up vaccine prices and encourage stockpiling. Also read: A Pandemic Investigation Reveals WHO and China Should Have Acted Faster "Ultimately, this action will only prolong the pandemic, the restrictions needed to overcome it, and human and economic suffering," he added.

 

"Ultimately, this action will only prolong the pandemic, the restrictions needed to overcome it, and human and economic suffering," he added. The WHO director-general also called for full commitment to the Covax global vaccine-sharing scheme, which will start rolling out next month. "My challenge for all member countries is to ensure that by the time of World Health Day on April 7, the Covid-19 vaccine is delivered in each country, as a symbol of hope for overcoming the pandemic and overcoming inequalities rooted in global health challenges," said Dr Tedros. . So far, more than 180 countries have signed up to the Covax initiative, which is supported by WHO and international vaccine advocacy groups. The aim is to unite countries into one block so that they have more power to negotiate with drug companies.

Also read: The story of Foreign Minister Retno being a Co-Chairs Covax AMC, being informed at 02.00 and immediately working 92 countries - all low or middle income - will have the vaccine paid for with funds from a number of donors. "We have obtained two billion doses from five manufacturers, with options for more than a billion more vaccine doses, and we plan to start deliveries in February," said Dr Tedros. How is the response? Responding to Dr Tedros' warning, UK Health Secretary Matt Hancock said, "Britain is the world's biggest supporter, financial supporter of a global program to ensure access to vaccines in all countries of the world."

More than four million people in the UK have received their first dose of the coronavirus vaccine , according to government data. People in their 70s and who are clinically particularly vulnerable in the UK are those currently on the vaccine. Last month, the People's Vaccine Alliance campaign agency said rich countries are stockpiling doses of Covid vaccines and that people living in poor countries will be left behind. It is said that nearly 70 low-income countries will only be able to vaccinate one in 10 people. Also read: WHO: The world is on the verge of a moral disaster in the distribution of the Covid-19 vaccine

Canada, in particular, has come under fire from a coalition that says the North American country has ordered enough doses of vaccine to vaccinate each Canadian five times. In December, Karina Gould, Canada's minister for international development, denied allegations that the country was stockpiling vaccines, saying any discussion of a vaccine surplus was "hypothetical" because doses had not been given. He said Canada provided $ 485 million (Rp. 5.3 trillion) to help developing countries overcome Covid-19.

What about the criticism from WHO and China? In their interim report, an independent panel of experts said China and the WHO should act more quickly during the early days of the coronavirus outbreak. The document says Beijing should have acted more decisively to localize the initial outbreak in the city of Wuhan which was first detected in late 2019. Experts also criticize the WHO for just announcing a global emergency on January 30, 2020. "The global pandemic warning system is incompatible," said the report. "The World Health Organization is powerless to do the job." The panel was chaired by former New Zealand Prime Minister Helen Clark and former Liberian President Ellen Johnson Sirleaf.

Guidance from the World Health Organization (WHO), each company that manufactures the Covid-19 vaccine must ensure that their vaccine efficacy level is at least 50 percent.

The organization, headquartered in Geneva, Switzerland, sets vaccine standards in a document called the Target Product Profile (TPP).

In this TPP there are several standard measures that are met with regard to the efficacy, period of protection, dose of administration and storage conditions of the vaccine. The document states that WHO wants an efficacy level of 70 percent with a minimum of 50 percent to be achieved.

According to Adrian Esterman, head of the BioStatistics and Epidemiology section at the University of South Australia, Adelaide, vaccine efficacy and effectiveness have simple differences.

"The level of efficacy is how well the vaccine works in clinical trials. The level of effectiveness is how the vaccine works when it is given to the general public," Esterman told ABC, January 14, 2021.

This means that if 100 people are vaccinated in a clinical trial and the efficacy level shows 50 percent, it means that 50 people who are vaccinated will be immune from the disease. Esterman explained that when the same vaccine is given to the general public, the level of efficacy can be different, because in trials, not all levels of society are included in the trial.

Meanwhile, Jodie McVernon, Director of Epidemiology and Infectious Diseases at the Doherty Institute in Melbourne, said the WHO's 50 percent target shows "the situation we are in right now" and authorities around the world are trying to find something that can help overcome it.

"What we see now is an overwhelmed health care system, a deteriorating economic condition with its social impact and many deaths," said McVernon.

Sinovac

The Food and Drug Administration (BPOM) has announced the efficacy or level of efficacy of the Sinovac vaccine which was clinically tested in Indonesia, precisely in Bandung, West Java, on January 12, 2021. The efficacy of the Covid-19 vaccine developed by Sinovac Biotech from China is stated at 65, 3 percent.

That figure is lower than the efficacy of the Sinovac vaccine tested in Turkey and Brazil. The resulting pre-announced efficacy claims were 91.2 percent and 78.0 percent, respectively.

Regarding the different efficacy of the clinical trial results for the Sinovac vaccine, the National Commission on Drug Assessment Team, Jarir At Thobari, explained a number of factors that may be the cause. "First, the epidemiology of Covid-19 in Indonesia itself," said Jarir in a press conference, Monday, January 11, 2021.

Other factors, Jarir said, are people's behavior, the process of transmission from one person to another, and the characteristics of the population or subjects that are included in the research. In Turkey, said Jarir, the subjects of the clinical trials are 20 percent of health workers and 80 percent of people at high risk.

Even with clinical trials in Brazil. "This is a high risk of transmission, it could result in a higher incidence or efficacy," he said.

Meanwhile in Bandung, Jarir compared, the vaccine volunteers involved came from the general population. According to Jarir, this would actually be good information for the use of the vaccine in Indonesia. "Because the general population has that much protection."